Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Magrath

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Sangre|February 1, 1990
[Molecular analysis in Argentinian patients with Burkitt's lymphoma]M I Gutiérrez, F Barriga, B Díez, et al.
Developments in Biological Standardization|January 1, 1984
Antigenic analysis of poliovirus type 3 using monoclonal antibodiesM Ferguson, P D Minor, D I Magrath, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1986
Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphomaP G Pelicci, D M Knowles, I Magrath, et al.
British Medical Journal|March 31, 1979
Immunity of children to diphtheria, tetanus, and poliomyelitisD Bainton, M Freeman, D I Magrath, et al.
Journal of the National Cancer Institute|September 1, 1982
Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell linesP Gerber, D Ablashi, I Magrath, et al.
Nature Genetics|September 1, 1993
Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomasK Bhatia, K Huppi, G Spangler, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of ifosfamide in the treatment of recurrent sarcomas in young peopleI Magrath, J Sandlund, A Raynor, et al.
Oncogene|September 1, 1991
Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytesK Bhatia, K Huppi, T McKeithan, et al.
Blood|August 1, 1994
Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomasK Bhatia, G Spangler, G Gaidano, et al.
Vaccine|August 1, 1989
Durability of immunity to diphtheria, tetanus and poliomyelitis after a three dose immunization schedule completed in the first eight months of lifeA E Jones, A Johns, D I Magrath, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Sangre|February 1, 1990
[Molecular analysis in Argentinian patients with Burkitt's lymphoma]M I Gutiérrez, F Barriga, B Díez, et al.
Developments in Biological Standardization|January 1, 1984
Antigenic analysis of poliovirus type 3 using monoclonal antibodiesM Ferguson, P D Minor, D I Magrath, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1986
Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphomaP G Pelicci, D M Knowles, I Magrath, et al.
British Medical Journal|March 31, 1979
Immunity of children to diphtheria, tetanus, and poliomyelitisD Bainton, M Freeman, D I Magrath, et al.
Journal of the National Cancer Institute|September 1, 1982
Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell linesP Gerber, D Ablashi, I Magrath, et al.
Nature Genetics|September 1, 1993
Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomasK Bhatia, K Huppi, G Spangler, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of ifosfamide in the treatment of recurrent sarcomas in young peopleI Magrath, J Sandlund, A Raynor, et al.
Oncogene|September 1, 1991
Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytesK Bhatia, K Huppi, T McKeithan, et al.
Blood|August 1, 1994
Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomasK Bhatia, G Spangler, G Gaidano, et al.
Vaccine|August 1, 1989
Durability of immunity to diphtheria, tetanus and poliomyelitis after a three dose immunization schedule completed in the first eight months of lifeA E Jones, A Johns, D I Magrath, et al.
Pageof 10